首页 > 最新文献

Asploro journal of biomedical and clinical case reports最新文献

英文 中文
Clinical Efficacy of Imeglimin (Twymeeg) for Elderly Patient with Type 2 Diabetes Mellitus (T2DM) 依美美明治疗老年2型糖尿病的临床疗效观察
Pub Date : 2022-02-21 DOI: 10.36502/2022/asjbccr.6259
M. Okada, H. Bando, Noboru Iwatsuki, T. Ogawa, K. Sakamoto
Background: As an oral hypoglycaemic agent (OHA), imeglimin (Twymeeg) has been recently introduced to clinical practice for patients with type 2 diabetes mellitus (T2DM) as Twymeeg. It has beneficial pharmacological mechanisms, which are improving insulin secretion, increasing insulin sensitivity, and decreasing insulin resistance.Case Presentation: The case is 84-year-old man with mild cognitive impairment (MCI) for 3 years. He visited late August, 2021 our clinic for general malaise and was pointed out to have post-prandial blood glucose 336 mg/dL and HbA1c 8.6%. He was diagnosed with T2DM.Results: He was started to be given imeglimin 1000mg twice a day, and then HbA1c value was decreased to 7.3% in 4 weeks and 5.7% in 8 weeks. During 9-12 weeks, he felt loss of appetite and reduced food intake. Biochemical examination on 12 weeks showed decreased values of TP, Alb, HbA1c, glucose, free T3, and normal values of TSH, free T4. Doses of imeglimin were 500 mg twice a day for 9-12 weeks and discontinued after 12 weeks.Discussion: Regarding appetite loss, possible causes may include MCI, previous history of gallbladder dyskinesia, adverse effect of imeglimin, and so on. Further development of research will be expected for imeglimin in the future.
背景:作为一种口服降糖药(OHA),依格列明(Twymeeg)最近被引入2型糖尿病(T2DM)患者的临床实践。它具有有益的药理学机制,包括改善胰岛素分泌、增加胰岛素敏感性和降低胰岛素抵抗。病例介绍:该病例为84岁男性,患有轻度认知障碍(MCI)3年。他于2021年8月下旬因全身不适就诊于我们的诊所,并被指出餐后血糖为336 mg/dL,HbA1c为8.6%。他被诊断为T2DM。结果:他开始每天两次服用1000mg的依格列明,然后HbA1c值在4周内降至7.3%,在8周内降至5.7%。在9-12周期间,他感到食欲不振,食物摄入减少。12周生化检查显示TP、Alb、HbA1c、葡萄糖、游离T3值降低,TSH、游离T4值正常。依格列明的剂量为500mg,每天两次,持续9-12周,12周后停用。讨论:关于食欲下降,可能的原因包括MCI、既往胆囊运动障碍史、依格列明的不良反应等。未来将对依格列明进行进一步的研究。
{"title":"Clinical Efficacy of Imeglimin (Twymeeg) for Elderly Patient with Type 2 Diabetes Mellitus (T2DM)","authors":"M. Okada, H. Bando, Noboru Iwatsuki, T. Ogawa, K. Sakamoto","doi":"10.36502/2022/asjbccr.6259","DOIUrl":"https://doi.org/10.36502/2022/asjbccr.6259","url":null,"abstract":"Background: As an oral hypoglycaemic agent (OHA), imeglimin (Twymeeg) has been recently introduced to clinical practice for patients with type 2 diabetes mellitus (T2DM) as Twymeeg. It has beneficial pharmacological mechanisms, which are improving insulin secretion, increasing insulin sensitivity, and decreasing insulin resistance.\u0000Case Presentation: The case is 84-year-old man with mild cognitive impairment (MCI) for 3 years. He visited late August, 2021 our clinic for general malaise and was pointed out to have post-prandial blood glucose 336 mg/dL and HbA1c 8.6%. He was diagnosed with T2DM.\u0000Results: He was started to be given imeglimin 1000mg twice a day, and then HbA1c value was decreased to 7.3% in 4 weeks and 5.7% in 8 weeks. During 9-12 weeks, he felt loss of appetite and reduced food intake. Biochemical examination on 12 weeks showed decreased values of TP, Alb, HbA1c, glucose, free T3, and normal values of TSH, free T4. Doses of imeglimin were 500 mg twice a day for 9-12 weeks and discontinued after 12 weeks.\u0000Discussion: Regarding appetite loss, possible causes may include MCI, previous history of gallbladder dyskinesia, adverse effect of imeglimin, and so on. Further development of research will be expected for imeglimin in the future.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44807037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Development of Febrile Seizures in Children with Iron Deficiency Anemia 缺铁性贫血患儿热性惊厥的发展
Pub Date : 2022-02-15 DOI: 10.36502/2022/asjbccr.6258
Juan Pablo Gualdrón Moncada, Ana María Caballero Mieles, Alexandra Paola Arrieta González, Valeria Olarte Manjarres, Natalia Andrea Cuevas Florez, Laura Vanessa Molina Torres, Diana Lisseth Rodriguez Paredes, Erika Paola Ramirez Escobar, Mayra Alejandra Santander Maury
A febrile seizure is a seizure that occurs in children with a temperature of 38 ºC or more, common in pediatric patients between the ages of 6 to 60 months without intracranial infections, metabolic disorder, or a history of seizures without fever. In 50% of children the first febrile seizure occurs at 2 years and in 90% before 3 years, anemia is also a frequent pathology in pediatric patients, in fact, the figures of the World Health Organization (WHO), point out that iron deficiency anemia attacks children under five years of age, occurring worldwide around 799 million, an average, in the last 10 years, of 42%. And in Latin America, the figure is 23%. Iron deficiency anemia can predispose to the development of febrile seizures because iron plays a crucial role in the transport of oxygen to all tissues, its deficiency also produces a dysfunction of myelination, tyrosine, and tryptophan synthesis hydroxylase, which are necessary for the release of neurotransmitters, therefore, if said neurotransmitters are not released, the brain synapse can be altered and lead to a seizure. Therefore, it is important and relevant to recognize these concepts and the intimate relationship between them, in addition to the risk factors that can trigger them, in order to promote the reduction of the risk of presenting these diseases in vulnerable groups such as pediatric patients.
发热性惊厥是指发生在体温为38℃或更高的儿童中的惊厥,常见于6至60个月的儿科患者,无颅内感染、代谢紊乱或无发热的惊厥史。在50%的儿童中,第一次发热性癫痫发作发生在2岁,90%发生在3岁之前,贫血也是儿科患者的常见病理,事实上,世界卫生组织(WHO)的数据指出,缺铁性贫血袭击5岁以下儿童,在世界范围内发生约7.99亿,在过去10年中平均为42%。在拉丁美洲,这个数字是23%。缺铁性贫血可诱发发热性癫痫发作,因为铁在所有组织的氧气运输中起着至关重要的作用,缺铁也会导致髓鞘形成、酪氨酸和色氨酸合成羟化酶功能障碍,这些是释放神经递质所必需的,因此,如果这些神经递质不释放,脑突触就会改变,导致癫痫发作。因此,认识到这些概念及其之间的密切关系,以及可能引发这些概念的风险因素,以促进减少儿科患者等弱势群体出现这些疾病的风险,是重要和相关的。
{"title":"Development of Febrile Seizures in Children with Iron Deficiency Anemia","authors":"Juan Pablo Gualdrón Moncada, Ana María Caballero Mieles, Alexandra Paola Arrieta González, Valeria Olarte Manjarres, Natalia Andrea Cuevas Florez, Laura Vanessa Molina Torres, Diana Lisseth Rodriguez Paredes, Erika Paola Ramirez Escobar, Mayra Alejandra Santander Maury","doi":"10.36502/2022/asjbccr.6258","DOIUrl":"https://doi.org/10.36502/2022/asjbccr.6258","url":null,"abstract":"A febrile seizure is a seizure that occurs in children with a temperature of 38 ºC or more, common in pediatric patients between the ages of 6 to 60 months without intracranial infections, metabolic disorder, or a history of seizures without fever. In 50% of children the first febrile seizure occurs at 2 years and in 90% before 3 years, anemia is also a frequent pathology in pediatric patients, in fact, the figures of the World Health Organization (WHO), point out that iron deficiency anemia attacks children under five years of age, occurring worldwide around 799 million, an average, in the last 10 years, of 42%. And in Latin America, the figure is 23%. Iron deficiency anemia can predispose to the development of febrile seizures because iron plays a crucial role in the transport of oxygen to all tissues, its deficiency also produces a dysfunction of myelination, tyrosine, and tryptophan synthesis hydroxylase, which are necessary for the release of neurotransmitters, therefore, if said neurotransmitters are not released, the brain synapse can be altered and lead to a seizure. Therefore, it is important and relevant to recognize these concepts and the intimate relationship between them, in addition to the risk factors that can trigger them, in order to promote the reduction of the risk of presenting these diseases in vulnerable groups such as pediatric patients.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47924204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-partum Eclampsia Complicated by Cerebral Venous Thrombosis: Case Report 产后子痫并发脑静脉血栓1例
Pub Date : 2022-01-22 DOI: 10.36502/2022/asjbccr.6257
Jacquelyn A Combs, Teja Narra, Conway Ou, Deyna Monta Velaz, Justin Chatten-Brown, L. Ranasinghe
Cerebral Vein Thrombosis associated with preeclampsia is a rare phenomenon that is not fully understood and presents a potentially challenging situation for treatment and future management. This case presents a 25-year old female with a history of gestational diabetes and hypertriglyceridemia presenting three days post-partum for an eclamptic seizure complicated by cerebral vein thrombosis and HELLP syndrome. The patient’s presenting symptoms were alleviated by eclampsia procedure, anti-anxiety medication, and two different types of anticoagulation. Thrombectomy was not indicated, as imaging did not suggest any large vein clotting. Future check-ins, as well as careful considerations in the event of future pregnancies, should be pursued by the physicians. Testing and gaining a better understanding of the pathophysiology behind cerebral vein thrombosis proves to be difficult as the occurrence is rare, but looking to previous literature to further an understanding of eclampsia and how it progresses in the body may help to provide a greater insight into similar cases and the approach that should be used in said cases.
脑静脉血栓形成与先兆子痫是一种罕见的现象,尚未完全了解,并提出了一个潜在的挑战的情况下,治疗和未来的管理。本病例是一名25岁女性,有妊娠糖尿病和高甘油三酯血症病史,产后3天因惊厥发作并发脑静脉血栓形成和HELLP综合征而出现。经子痫手术、抗焦虑药物及两种不同类型的抗凝治疗后,患者的症状得到缓解。由于影像学检查未发现任何大静脉凝血,故不建议取栓。未来的检查,以及在未来怀孕的情况下的仔细考虑,应该由医生追求。检测和更好地了解脑静脉血栓形成背后的病理生理学是很困难的,因为这种情况很少发生,但回顾以往的文献,进一步了解子痫及其在体内的进展,可能有助于对类似病例提供更深入的了解,以及在上述病例中应该使用的方法。
{"title":"Post-partum Eclampsia Complicated by Cerebral Venous Thrombosis: Case Report","authors":"Jacquelyn A Combs, Teja Narra, Conway Ou, Deyna Monta Velaz, Justin Chatten-Brown, L. Ranasinghe","doi":"10.36502/2022/asjbccr.6257","DOIUrl":"https://doi.org/10.36502/2022/asjbccr.6257","url":null,"abstract":"Cerebral Vein Thrombosis associated with preeclampsia is a rare phenomenon that is not fully understood and presents a potentially challenging situation for treatment and future management. This case presents a 25-year old female with a history of gestational diabetes and hypertriglyceridemia presenting three days post-partum for an eclamptic seizure complicated by cerebral vein thrombosis and HELLP syndrome. The patient’s presenting symptoms were alleviated by eclampsia procedure, anti-anxiety medication, and two different types of anticoagulation. Thrombectomy was not indicated, as imaging did not suggest any large vein clotting. Future check-ins, as well as careful considerations in the event of future pregnancies, should be pursued by the physicians. Testing and gaining a better understanding of the pathophysiology behind cerebral vein thrombosis proves to be difficult as the occurrence is rare, but looking to previous literature to further an understanding of eclampsia and how it progresses in the body may help to provide a greater insight into similar cases and the approach that should be used in said cases.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45848763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Germ Cell Neoplasia in Situ of the Testis and Azoospermia: Case Report and Review of the Literature 睾丸原位生殖细胞增生和无精子症:病例报告及文献复习
Pub Date : 2022-01-15 DOI: 10.36502/2022/asjbccr.6256
Federico Rovegno, C. Yepes, Jonathan Finkelstein, A. Rovegno
An increased risk of testicular cancer in men with infertility and poor semen quality has been reported. We aim to present a patient who was being studied for infertility and incidentally found a testicular nodule, discuss management and prevalence of small testicular masses.
据报道,不育和精液质量差的男性患睾丸癌症的风险增加。我们的目的是介绍一名正在接受不孕不育研究的患者,偶然发现睾丸结节,讨论小睾丸肿块的处理和患病率。
{"title":"Germ Cell Neoplasia in Situ of the Testis and Azoospermia: Case Report and Review of the Literature","authors":"Federico Rovegno, C. Yepes, Jonathan Finkelstein, A. Rovegno","doi":"10.36502/2022/asjbccr.6256","DOIUrl":"https://doi.org/10.36502/2022/asjbccr.6256","url":null,"abstract":"An increased risk of testicular cancer in men with infertility and poor semen quality has been reported. We aim to present a patient who was being studied for infertility and incidentally found a testicular nodule, discuss management and prevalence of small testicular masses.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45954760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anaplastic Multiple Myeloma: Case Series and Literature Review 间变性多发性骨髓瘤:病例系列和文献回顾
Pub Date : 2022-01-15 DOI: 10.36502/2022/asjbccr.6255
Jian Wu, E.Y.-L. Chu, Cristiana Costa Chase, T. Choi, C. Gasparetto, K. Young, Yubin Kang
Background: Anaplastic multiple myeloma (AMM) is a very rare but distinct subtype of multiple myeloma (MM) with an extremely poor prognosis. Due to its rarity, AMM lacks detailed descriptions and clear definitions. Moreover, there is no consensus on the treatment and evidence suggests that AMM responds poorly to several novel therapies. We conducted a literature review and retrospective case series to determine clinical characteristics, pathological features, and outcomes of AMM. Case Presentation: Published case reports and case series of AMM since 1983 were systematically extracted and reviewed. A total of 52 patients with AMM were reported in the PUBMED since 1983, including 26 males (50%) and 26 females (50%). The age ranged from 29 years old to 85 years old, with a mean age of 57.02 years old. Most of the patients presented with bone pain (23, 44.2%), fatigue (18, 34.6%), plasmacytoma (18, 34.6%) and weight loss (7, 13.5%). The median survival of the patients was 4 months. To investigate the outcomes of patients with AMM in the current era of treatment, a series of 14 patients with AMM diagnosed at our institute between December 2012 and July 2021was retrospectively analyzed. Our retrospective case series consisted of 12 males (85.7%) and 2 females (14.3%), with a mean age of 59 years old. Most of our AMM patients displayed bone lytic lesions as a common manifestation. The common cytogenetic abnormality was 1q amplification. All patients received standard combination chemotherapy consisting of proteasome inhibitors and/or immunomodulatory agents, and half of the patients underwent autologous hematopoietic stem cell transplantation. The median progression-free survival (PFS) and overall survival (OS) for our 14 AMM patients were 0.84 years and 1.52 years, respectively, which was significantly worse than the regular MM patients treated at our institute from 2003–2013 who had a PFS of 2.28 years and OS of 4.92 years. Conclusions: AMM is a very rare, morphologically distinct variant of MM. It has adverse cytogenetics and an aggressive course. It is often resistant to standard chemotherapy and presents with an extremely low survival rate.
背景:间变性多发性骨髓瘤(AMM)是一种非常罕见但独特的多发性骨瘤(MM)亚型,预后极差。由于其稀有性,AMM缺乏详细的描述和明确的定义。此外,在治疗方面还没有达成共识,有证据表明AMM对几种新疗法的反应不佳。我们进行了文献综述和回顾性病例系列,以确定AMM的临床特征、病理特征和结果。病例介绍:对1983年以来发表的AMM病例报告和病例系列进行了系统的提取和回顾。自1983年以来,PUBMED共报告了52名AMM患者,包括26名男性(50%)和26名女性(50%)。年龄29~85岁,平均57.02岁。大多数患者表现为骨痛(23,44.2%)、疲劳(18,34.6%)、浆细胞瘤(18,3.46%)和体重减轻(7,13.5%)。患者的中位生存期为4个月。为了研究AMM患者在当前治疗时代的结果,我们对2012年12月至2021年7月在我们研究所诊断的14名AMM患者进行了回顾性分析。我们的回顾性病例系列包括12名男性(85.7%)和2名女性(14.3%),平均年龄59岁。我们的大多数AMM患者表现出溶骨病变是一种常见的表现。常见的细胞遗传学异常为1q扩增。所有患者均接受了由蛋白酶体抑制剂和/或免疫调节剂组成的标准联合化疗,其中一半患者接受了自体造血干细胞移植。我们的14名AMM患者的中位无进展生存期(PFS)和总生存期(OS)分别为0.84年和1.52年,这明显低于2003-2013年在我们研究所接受治疗的常规MM患者,后者的PFS为2.28年,OS为4.92年。结论:AMM是MM的一种非常罕见的、形态上独特的变体。它具有不良的细胞遗传学和侵袭性过程。它通常对标准化疗具有耐药性,并且存活率极低。
{"title":"Anaplastic Multiple Myeloma: Case Series and Literature Review","authors":"Jian Wu, E.Y.-L. Chu, Cristiana Costa Chase, T. Choi, C. Gasparetto, K. Young, Yubin Kang","doi":"10.36502/2022/asjbccr.6255","DOIUrl":"https://doi.org/10.36502/2022/asjbccr.6255","url":null,"abstract":"Background: Anaplastic multiple myeloma (AMM) is a very rare but distinct subtype of multiple myeloma (MM) with an extremely poor prognosis. Due to its rarity, AMM lacks detailed descriptions and clear definitions. Moreover, there is no consensus on the treatment and evidence suggests that AMM responds poorly to several novel therapies. We conducted a literature review and retrospective case series to determine clinical characteristics, pathological features, and outcomes of AMM. Case Presentation: Published case reports and case series of AMM since 1983 were systematically extracted and reviewed. A total of 52 patients with AMM were reported in the PUBMED since 1983, including 26 males (50%) and 26 females (50%). The age ranged from 29 years old to 85 years old, with a mean age of 57.02 years old. Most of the patients presented with bone pain (23, 44.2%), fatigue (18, 34.6%), plasmacytoma (18, 34.6%) and weight loss (7, 13.5%). The median survival of the patients was 4 months. To investigate the outcomes of patients with AMM in the current era of treatment, a series of 14 patients with AMM diagnosed at our institute between December 2012 and July 2021was retrospectively analyzed. Our retrospective case series consisted of 12 males (85.7%) and 2 females (14.3%), with a mean age of 59 years old. Most of our AMM patients displayed bone lytic lesions as a common manifestation. The common cytogenetic abnormality was 1q amplification. All patients received standard combination chemotherapy consisting of proteasome inhibitors and/or immunomodulatory agents, and half of the patients underwent autologous hematopoietic stem cell transplantation. The median progression-free survival (PFS) and overall survival (OS) for our 14 AMM patients were 0.84 years and 1.52 years, respectively, which was significantly worse than the regular MM patients treated at our institute from 2003–2013 who had a PFS of 2.28 years and OS of 4.92 years. Conclusions: AMM is a very rare, morphologically distinct variant of MM. It has adverse cytogenetics and an aggressive course. It is often resistant to standard chemotherapy and presents with an extremely low survival rate.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":"5 1","pages":"1 - 11"},"PeriodicalIF":0.0,"publicationDate":"2022-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41986384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Further Hospital Art Development of Masking Tape Using Thin Film Sheet 薄膜胶带在医院艺术上的进一步发展
Pub Date : 2021-12-30 DOI: 10.36502/2021/asjbccr.6254
Kei Tanaka, Shinji Nagahiro, H. Bando
The authors and collaborators have continued practice of hospital art in the university and community hospitals and various research with experts. The material for hospital art is masking tape which is easily made and attached for everyone. Formerly, we have conducted artwork in front of the wall, which took a long time. Currently, we have tried to take the most advantage of the thin-film sheet. Our staff can prepare artwork with a size of 20 cm square in advance. Many square parts with double-sided attachment tape can be gathered together, which is completed and useful in a short time.
作者和合作者继续在大学和社区医院实践医院艺术,并与专家进行各种研究。医院艺术的材料是掩蔽胶带,它很容易制作并贴在每个人身上。以前,我们在墙前进行艺术创作,花了很长时间。目前,我们已经尝试利用薄膜片材的最大优势。我们的工作人员可以提前准备20平方厘米大小的艺术品。许多带有双面胶带的方形零件可以聚集在一起,在短时间内完成并有用。
{"title":"Further Hospital Art Development of Masking Tape Using Thin Film Sheet","authors":"Kei Tanaka, Shinji Nagahiro, H. Bando","doi":"10.36502/2021/asjbccr.6254","DOIUrl":"https://doi.org/10.36502/2021/asjbccr.6254","url":null,"abstract":"The authors and collaborators have continued practice of hospital art in the university and community hospitals and various research with experts. The material for hospital art is masking tape which is easily made and attached for everyone. Formerly, we have conducted artwork in front of the wall, which took a long time. Currently, we have tried to take the most advantage of the thin-film sheet. Our staff can prepare artwork with a size of 20 cm square in advance. Many square parts with double-sided attachment tape can be gathered together, which is completed and useful in a short time.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49204479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Several Effective Measures for Minus Excess Mortality of COVID-19 in Japan Including Mutual Interrelationships and Long-Term Care Facilities (LTCF) 包括相互关系和长期护理设施在内的日本降低COVID-19超额死亡率的若干有效措施
Pub Date : 2021-11-16 DOI: 10.36502/2021/asjbccr.6253
H. Bando
The impact of COVID-19 can be shown by life expectancy, excess death and total years of life lost (YLL). United States showed life expectancy minus 1.67 years, excess deaths 375,235 and total YLL 7,362,555. The excess death of Japan has remained minus value for long, in which long-term care facilities (LTCF) may contribute. LTCF has characteristic points as i) mutual interrelationships between hospitals, medical societies and prefectural offices, ii) rapid communication channels for regulatory official authorities, iii) high degree of citizenship and cooperation of all Japanese people for daily life and iv) mild lockdown without any punishment with declaration.
COVID-19的影响可以通过预期寿命、超额死亡和总寿命损失年数来体现。美国的预期寿命减少1.67岁,超额死亡375,235人,总死亡人数为7,362,555人。日本的超额死亡率长期处于负值,其中长期护理设施(LTCF)可能有所贡献。LTCF的特点是:i)医院、医学会和县办事处之间的相互关系;ii)监管当局的快速沟通渠道;iii)所有日本人在日常生活中高度公民化和合作;iv)轻度封锁,没有任何处罚。
{"title":"Several Effective Measures for Minus Excess Mortality of COVID-19 in Japan Including Mutual Interrelationships and Long-Term Care Facilities (LTCF)","authors":"H. Bando","doi":"10.36502/2021/asjbccr.6253","DOIUrl":"https://doi.org/10.36502/2021/asjbccr.6253","url":null,"abstract":"The impact of COVID-19 can be shown by life expectancy, excess death and total years of life lost (YLL). United States showed life expectancy minus 1.67 years, excess deaths 375,235 and total YLL 7,362,555. The excess death of Japan has remained minus value for long, in which long-term care facilities (LTCF) may contribute. LTCF has characteristic points as i) mutual interrelationships between hospitals, medical societies and prefectural offices, ii) rapid communication channels for regulatory official authorities, iii) high degree of citizenship and cooperation of all Japanese people for daily life and iv) mild lockdown without any punishment with declaration.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42289514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
A Case Report of Delayed Hemothorax Complicated by Fibrothorax 迟发性血胸合并纤维胸1例
Pub Date : 2021-11-02 DOI: 10.36502/2021/asjbccr.6252
Tanvi Chokshi, Alexandra Theodosopoulos, E. Wilson, Michael Ysit, Sameir Alhadi, L. Ranasinghe
Delayed hemothorax is a potentially life-threatening complication of thoracic trauma that should be carefully considered in all patients presenting with thoracic injury. We report a case of delayed hemothorax in a 77-year-old male presenting eleven days’ status post multiple right mid- to high-rib fractures. His case was complicated by retained hemothorax after CT-guided chest-tube with subsequent video-assisted tube thoracostomy (VATS) revealing fibrothorax necessitating conversion to open thoracotomy. Known risk factors for development of delayed hemothorax include older patient age, three or more rib fractures, and presence of mid- to high-rib fractures, and should be used in risk stratification of thoracic trauma. Tube thoracostomy is often sufficient in management of delayed hemothorax. In rare cases, hemothoraces can be complicated by retained hemothorax or fibrothorax, which require more invasive therapy and carry greater morbidity and mortality.
迟发性血胸是胸外伤的一种潜在的危及生命的并发症,所有出现胸外伤的患者都应仔细考虑。我们报告一例延迟性血胸在一个77岁的男性呈现11天的状态后,多发右中至高位肋骨骨折。他的病例在ct引导下胸腔插管和随后的视频辅助管开胸术(VATS)后发现纤维胸,需要转开胸。已知发生迟发性血胸的危险因素包括患者年龄较大、三处或更多肋骨骨折、存在中高肋骨折,并应用于胸部创伤的风险分层。导管开胸术通常足以治疗迟发性血胸。在极少数情况下,血胸可并发保留性血胸或纤维胸,这需要更多的侵入性治疗,并具有更高的发病率和死亡率。
{"title":"A Case Report of Delayed Hemothorax Complicated by Fibrothorax","authors":"Tanvi Chokshi, Alexandra Theodosopoulos, E. Wilson, Michael Ysit, Sameir Alhadi, L. Ranasinghe","doi":"10.36502/2021/asjbccr.6252","DOIUrl":"https://doi.org/10.36502/2021/asjbccr.6252","url":null,"abstract":"Delayed hemothorax is a potentially life-threatening complication of thoracic trauma that should be carefully considered in all patients presenting with thoracic injury. We report a case of delayed hemothorax in a 77-year-old male presenting eleven days’ status post multiple right mid- to high-rib fractures. His case was complicated by retained hemothorax after CT-guided chest-tube with subsequent video-assisted tube thoracostomy (VATS) revealing fibrothorax necessitating conversion to open thoracotomy. Known risk factors for development of delayed hemothorax include older patient age, three or more rib fractures, and presence of mid- to high-rib fractures, and should be used in risk stratification of thoracic trauma. Tube thoracostomy is often sufficient in management of delayed hemothorax. In rare cases, hemothoraces can be complicated by retained hemothorax or fibrothorax, which require more invasive therapy and carry greater morbidity and mortality.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45027676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report and Highlight Clues on the Diagnosis of Pilomatrical Carcinoma 毛细胞癌的病例报告及诊断要点
Pub Date : 2021-10-27 DOI: 10.36502/2021/asjbccr.6251
Lewkowicz Milagros, Greco Alejandro, Lezcano Gabriel, Cachau Victoria, Díaz Florencia
Pilomatrical Carcinoma (PC) is a rare malignant adnexal tumor with matrical differentiation. Its benign counterpart (Pilomatrixoma) is diagnosed much more frequently in daily pathological practice. Both entities share genetic alterations but the malignant counterpart acquires mutations that make it develop an aggressive behavior [1].We describe a 33-year-old man who presented with a 7 x 6 cm nodular ulcerated lesion in the left ear with markedly accelerated growth in the last month. Incisional biopsy was referred to us with suspicion of squamous cell carcinoma versus pyogenic granuloma.Histologic sections showed ulcerated fragments infiltrated by a basaloid cell proliferation interspersed with groups of “ghost cells”. The neoplastic cells were arranged in irregular sheets with infiltrative borders. Groups of Squamous cells with trichilemmal keratinization and foci of necrosis were also identified. The biopsy was diagnosed as an adnexal neoplasm with pilomatrical differentiation, suggesting its complete resection with safety margins due to the presence of aggressive characteristics. The subsequent study of the excisional biopsy showed similar characteristics to those previously described. Notoriously, focal infiltration of the auricular cartilage was identified, leading us to the undoubted diagnosis of pilomatrical carcinoma.
毛瘤样癌(PC)是一种罕见的伴有基质分化的附件恶性肿瘤。它的良性对应物(毛瘤)在日常病理实践中被诊断得更频繁。这两种实体都有共同的基因改变,但恶性对应物获得突变,使其发展为攻击性行为[1]。我们描述了一名33岁的男子,他在左耳出现7 x 6厘米的结节性溃疡病变,上个月生长明显加快。我们怀疑是鳞状细胞癌还是化脓性肉芽肿。组织学切片显示溃疡碎片被基底样细胞增殖浸润,其间穿插着一组“幽灵细胞”。肿瘤细胞呈不规则片状排列,边界呈浸润性。还发现了具有毛膜角化和坏死灶的鳞状细胞群。活检被诊断为具有毛基质分化的附件肿瘤,这表明由于存在侵袭性特征,其完全切除具有安全边际。随后对切除活检的研究显示出与先前描述的相似的特征。臭名昭著的是,发现了耳廓软骨的局灶性浸润,这使我们对毛基质癌的诊断毫无疑问。
{"title":"Case Report and Highlight Clues on the Diagnosis of Pilomatrical Carcinoma","authors":"Lewkowicz Milagros, Greco Alejandro, Lezcano Gabriel, Cachau Victoria, Díaz Florencia","doi":"10.36502/2021/asjbccr.6251","DOIUrl":"https://doi.org/10.36502/2021/asjbccr.6251","url":null,"abstract":"Pilomatrical Carcinoma (PC) is a rare malignant adnexal tumor with matrical differentiation. Its benign counterpart (Pilomatrixoma) is diagnosed much more frequently in daily pathological practice. Both entities share genetic alterations but the malignant counterpart acquires mutations that make it develop an aggressive behavior [1].\u0000\u0000We describe a 33-year-old man who presented with a 7 x 6 cm nodular ulcerated lesion in the left ear with markedly accelerated growth in the last month. Incisional biopsy was referred to us with suspicion of squamous cell carcinoma versus pyogenic granuloma.\u0000\u0000Histologic sections showed ulcerated fragments infiltrated by a basaloid cell proliferation interspersed with groups of “ghost cells”. The neoplastic cells were arranged in irregular sheets with infiltrative borders. Groups of Squamous cells with trichilemmal keratinization and foci of necrosis were also identified. The biopsy was diagnosed as an adnexal neoplasm with pilomatrical differentiation, suggesting its complete resection with safety margins due to the presence of aggressive characteristics. The subsequent study of the excisional biopsy showed similar characteristics to those previously described. Notoriously, focal infiltration of the auricular cartilage was identified, leading us to the undoubted diagnosis of pilomatrical carcinoma.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45811891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychological Application for New Version of Tokyo University Egogram Battery 东京大学新版Egogram Battery的心理学应用
Pub Date : 2021-09-28 DOI: 10.36502/2021/asjbccr.6249
T. Yokoyama, H. Bando
Transactional Analysis (TA) has been a personality theory beneficial to mutual communication associated with the research of egogram. Tokyo University Egogram (TEG) has been a reliable psychological battery. TEG ver3 was recently introduced, which was applied to 98 university students. The results for 5 egogram factors were compared to previous standard values. Similar data were observed in Critical Parent(CP), Nurturing Parent(NP), and Adult(A). Higher tendency values (vs standard value) were found in male Free Child (FC) 12.3 vs 10.6, male Adapted Child (AC) 13.6 vs 10.0, and female AC 14.8 vs 10.8. Further study for TEG will be expected in the future.
交易分析(Transactional Analysis, TA)是一种与自我图研究相关的有利于相互交流的人格理论。东京大学的自我图谱(TEG)一直是一个可靠的心理电池。最近推出了TEG ver3,并对98名大学生进行了应用。将5个因子的结果与以往的标准值进行比较。在关键父母(CP)、养育父母(NP)和成人(A)中也观察到类似的数据。与标准值相比,男性自由儿童(FC) 12.3比10.6,男性适应儿童(AC) 13.6比10.0,女性AC 14.8比10.8。对TEG的进一步研究将在未来进行。
{"title":"Psychological Application for New Version of Tokyo University Egogram Battery","authors":"T. Yokoyama, H. Bando","doi":"10.36502/2021/asjbccr.6249","DOIUrl":"https://doi.org/10.36502/2021/asjbccr.6249","url":null,"abstract":"Transactional Analysis (TA) has been a personality theory beneficial to mutual communication associated with the research of egogram. Tokyo University Egogram (TEG) has been a reliable psychological battery. TEG ver3 was recently introduced, which was applied to 98 university students. The results for 5 egogram factors were compared to previous standard values. Similar data were observed in Critical Parent(CP), Nurturing Parent(NP), and Adult(A). Higher tendency values (vs standard value) were found in male Free Child (FC) 12.3 vs 10.6, male Adapted Child (AC) 13.6 vs 10.0, and female AC 14.8 vs 10.8. Further study for TEG will be expected in the future.","PeriodicalId":93523,"journal":{"name":"Asploro journal of biomedical and clinical case reports","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48555343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Asploro journal of biomedical and clinical case reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1